Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026U.S. SEC Regulation S-P: Compliance Deadline Approaching for Smaller EntitiesApril 30, 2026European Biotech Act I: Navigating the EDPB/EDPS Vision for the Future of Clinical TrialsApril 29, 2026Sidley Represents OppFi In Its Acquisition of BNCC and BNC National BankApril 29, 2026Sidley Represents Liberty Mutual in US$750 Million Senior Notes OfferingApril 23, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
